Corporate
Intuitive Surgical Returns to Its Roots: FDA Clears da Vinci 5 for Cardiac Surgery
Jan 26
You're signed outSign in or to get full access.
IS
INTUITIVE SURGICAL (ISRG)·Earnings Reports
Q3 2025
View earnings summary and analysis
Q2 2025
View earnings summary and analysis
Q1 2025
View earnings summary and analysis
Q4 2024
View earnings summary and analysis
Research analysts covering INTUITIVE SURGICAL.
Recent News about INTUITIVE SURGICAL
Corporate
Intuitive Surgical Crushes Q4 Estimates as da Vinci 5 Adoption Accelerates
Jan 23
Corporate
Intuitive Surgical Beats on Earnings, But Guides to Slowdown as Tariffs Take 120 Basis Points Off Margins
Jan 23
Corporate
Intuitive Surgical Crosses $10 Billion in Revenue, Stock Falls on Slowing Growth Outlook
Jan 15